Dimitrios Mathios, MD

---

---

My goal as a physician, surgeon, and scientist is to devise an individualized treatment plan for every patient I treat – not just focusing on prolonging their life, but providing them with a quality of life experience. Our team achieves this by listening to our patients, providing surgical excellence and collaborating with WashU experts to design the best steps forward.

Dr. Mathios

---

---

Research focus

Brain tumors are devastating for the individuals affected and present a challenge for the doctors taking care of them. Despite the technological and surgical advancements, many patients succumb to their disease and others have serious side effects related to their treatments. With my expertise in Cancer Immunology, Genetics and Epigenetics, I have applied these tools towards the development of treatments before they become symptomatic, and at a point when they are easily resectable or curable with other treatments that could lead to improved outcomes. The Molecular Neuro-oncology lab is focused on developing genomic and epigenomic approaches for the development of liquid biopsy assays for non-invasive detection of brain tumors. The work performed is multidisciplinary and includes physicians, molecular biologists, and bioinformaticians.

View all research, publications and collaborations in Google Scholar

---

Honors & leadership roles

• Grand Lodge of Greece Scholarship, 2004 – 2010 
• Summa cum Laude, Kapodistrian University of Athens School of Medicine, 2011
• Neurosurgery Residency Representative in the House Staff Council, The Johns Hopkins Hospital, 2019 – 2021
• Harvey Cushing Hunterian Research Award, Johns Hopkins University School of Medicine,  2021 
• Young Investigator Physician Scientist Research Award, Johns Hopkins University School of Medicine, 2022

---

Hospital appointments

Barnes-Jewish Hospital

Missouri Baptist Medical Center